Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-07-13 Sale | 2021-07-15 4:01 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $19.01 | $570,258 | 772,858 (Direct) | View |
| 2021-06-15 Sale | 2021-06-17 4:05 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $21.97 | $659,021 | 862,858 (Direct) | View |
| 2021-05-11 Sale | 2021-05-13 4:43 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $19.9 | $597,101 | 992,858 (Direct) | View |
| 2021-04-13 Sale | 2021-04-15 5:53 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $24.46 | $733,768 | 1,082,858 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 5:49 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 31,040 | $29.81 | $925,238 | 156,179 (Direct) | View |
| 2021-01-19 Sale | 2021-01-21 5:31 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $21.01 | $630,288 | 616,585 (Direct) | View |
| 2020-12-15 Sale | 2020-12-17 6:01 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 30,000 | $19.53 | $585,986 | 335,299 (Direct) | View |
| 2018-11-15 Sale | 2018-11-16 5:17 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $39.84 | $199,211 | 138,433 (Direct) | View |
| 2018-10-11 Sale | 2018-10-15 5:54 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $41.53 | $207,645 | 532,719 (Direct) | View |
| 2018-09-17 Sale | 2018-09-19 7:08 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $66.31 | $331,549 | 138,433 (Direct) | View |
| 2018-08-15 Sale | 2018-08-17 2:59 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $55.88 | $279,378 | 143,433 (Direct) | View |
| 2018-07-16 Sale | 2018-07-17 4:01 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $42.06 | $210,313 | 148,433 (Direct) | View |
| 2018-05-15 Sale | 2018-05-16 1:37 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $46.28 | $347,064 | 144,433 (Direct) | View |
| 2018-04-16 Sale | 2018-04-17 12:20 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $36 | $269,971 | 151,933 (Direct) | View |
| 2018-03-15 Sale | 2018-03-16 10:09 am | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $38.2 | $286,466 | 159,433 (Direct) | View |
| 2018-02-15 Sale | 2018-02-16 11:54 am | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $20 | $150,015 | 166,933 (Direct) | View |
| 2018-01-16 Sale | 2018-01-17 09:48 am | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $22.99 | $172,395 | 174,433 (Direct) | View |
| 2017-12-18 Sale | 2017-12-20 08:48 am | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $20.01 | $150,106 | 181,933 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-17 Option Award | 2022-06-17 4:27 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 5,542 | $2.03 | 8,439 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 7:08 pm | N/A 2032-06-09 | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-03-18 Option Award | 2022-03-18 4:05 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 2,897 | $3.02 | 2,897 (Direct) | View |
| 2022-02-07 Exercise | 2022-02-08 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $0 | 288,286 (Direct) | View |
| 2022-02-07 Exercise | 2022-02-08 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $0.39 | 288,286 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-10 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 40,000 | $0 | 288,286 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-10 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 40,000 | $0.39 | 288,286 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-11 4:58 pm | N/A 2031-08-08 | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 4:01 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 772,858 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 4:01 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 772,858 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 862,858 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 862,858 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-25 6:29 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 20,000 | $0 | 348,286 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-25 6:29 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 20,000 | $0.39 | 348,286 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 4:43 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 992,858 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 4:43 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 992,858 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:53 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 1,082,858 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:53 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 1,082,858 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 5:49 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 31,040 | $3.72 | 156,179 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 5:49 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 31,040 | $0 | 156,179 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-21 5:31 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $3.72 | 616,585 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-21 5:31 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 34,000 | $0 | 616,585 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-21 5:31 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 4,000 | $0.39 | 616,585 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 6:01 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 30,000 | $3.72 | 335,299 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 6:01 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 30,000 | $0 | 335,299 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 3,000 | $0 | 408,286 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 3,000 | $0.39 | 408,286 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 220,000 | $0 | 220,000 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:59 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 6,000 | $0 | 408,286 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:59 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 6,000 | $0.39 | 408,286 (Direct) | View |
| 2019-01-17 Exercise | 2019-01-17 5:52 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 9,000 | $0 | 408,286 (Direct) | View |
| 2019-01-17 Exercise | 2019-01-17 5:52 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 9,000 | $0.39 | 408,286 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 5:28 pm | N/A 2029-01-02 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 225,000 | $0 | 225,000 (Direct) | View |
| 2018-11-15 Exercise | 2018-11-16 5:17 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $3.72 | 138,433 (Direct) | View |
| 2018-11-15 Exercise | 2018-11-16 5:17 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $0 | 138,433 (Direct) | View |
| 2018-10-11 Exercise | 2018-10-15 5:54 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $3.72 | 532,719 (Direct) | View |
| 2018-10-11 Exercise | 2018-10-15 5:54 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 15,000 | $0 | 532,719 (Direct) | View |
| 2018-10-11 Exercise | 2018-10-15 5:54 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 10,000 | $0.39 | 532,719 (Direct) | View |
| 2018-09-17 Exercise | 2018-09-19 7:08 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $3.72 | 138,433 (Direct) | View |
| 2018-09-17 Exercise | 2018-09-19 7:08 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $0 | 138,433 (Direct) | View |
| 2018-08-15 Exercise | 2018-08-17 2:59 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $3.72 | 143,433 (Direct) | View |
| 2018-08-15 Exercise | 2018-08-17 2:59 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $0 | 143,433 (Direct) | View |
| 2018-07-16 Exercise | 2018-07-17 4:01 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $3.72 | 148,433 (Direct) | View |
| 2018-07-16 Exercise | 2018-07-17 4:01 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 5,000 | $0 | 148,433 (Direct) | View |
| 2018-07-16 Gift | 2018-07-17 4:01 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 1,000 | $0 | 148,433 (Direct) | View |
| 2018-05-31 Exercise | 2018-05-31 4:22 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 10,000 | $0 | 409,286 (Direct) | View |
| 2018-05-31 Exercise | 2018-05-31 4:22 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 10,000 | $0.39 | 409,286 (Direct) | View |
| 2018-05-15 Exercise | 2018-05-16 1:37 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $3.72 | 144,433 (Direct) | View |
| 2018-05-15 Exercise | 2018-05-16 1:37 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $0 | 144,433 (Direct) | View |
| 2018-04-16 Exercise | 2018-04-17 12:20 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $3.72 | 151,933 (Direct) | View |
| 2018-04-16 Exercise | 2018-04-17 12:20 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $0 | 151,933 (Direct) | View |
| 2018-03-15 Exercise | 2018-03-16 10:09 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $3.72 | 159,433 (Direct) | View |
| 2018-03-15 Exercise | 2018-03-16 10:09 am | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $0 | 159,433 (Direct) | View |
| 2018-02-15 Exercise | 2018-02-16 11:54 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $3.72 | 166,933 (Direct) | View |
| 2018-02-15 Exercise | 2018-02-16 11:54 am | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $0 | 166,933 (Direct) | View |
| 2018-01-16 Exercise | 2018-01-17 09:48 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $3.72 | 174,433 (Direct) | View |
| 2018-01-16 Exercise | 2018-01-17 09:48 am | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $0 | 174,433 (Direct) | View |
| 2018-01-02 Option Award | 2018-01-04 09:40 am | N/A 2028-01-02 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 75,000 | $0 | 75,000 (Direct) | View |
| 2017-12-18 Exercise | 2017-12-20 08:48 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $3.72 | 181,933 (Direct) | View |
| 2017-12-18 Exercise | 2017-12-20 08:48 am | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 7,500 | $0 | 181,933 (Direct) | View |